SAFETY AND TOLERABILITY OF RECURRENT HEPATITIS C TREATMENT IN POST LIVER AND LIVER/KIDNEY TRANSPLANT PATIENTS TREATED WITH LEDIPASVIR/SOFOSBUVIR WITH AND WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: SINGLE CENTER EXPERIENCE

被引：0
|
作者：
Selim, K. [1 ]
Elhazin, B. [1 ]
Long, W. [1 ]
Karmanova, M. [1 ]
Salazar, J. [1 ]
Volk, M. [1 ]
机构：
[1] Loma Linda Univ, Med Ctr, Inst Transplantat, Loma Linda, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-197
引用
收藏
页码：S788 / S789
页数：2
相关论文
共 50 条
  • [1] Outcome of Recurrent Hepatitis C Treatment in Post Liver and Liver/Kidney Transplant Patients Treated with Ledipasavir/Sofosbuvir with and without Ribavirin or Sofosbuvir with Ribavirin: Single Center Experience
    Selim, Khaled
    Elhazin, Bridgeida
    Long, Wen
    Salazar, Jennifer
    Karmanova, Marina
    Volk, Micheal
    [J]. TRANSPLANTATION, 2016, 100 : S124 - S124
  • [2] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center
    Pyrsopoulos, Nikolaos
    Lingiah, Vivek A.
    Sanaka, Sirish
    Fung, Phoenix
    Punnoose, Merlin
    [J]. HEPATOLOGY, 2016, 64 : 810A - 810A
  • [3] Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, Deann
    Orr, Jordan
    Zhang, Jie
    Venkata, Krishna V.
    Massoud, Omar I.
    [J]. HEPATOLOGY, 2016, 64 : 995A - 996A
  • [4] Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience
    Akin, Mete
    Buldukoglu, Osman Cagin
    Adanir, Haydar
    Suleymanlar, Inci
    Dincer, Dinc
    Yildirim, Bulent
    [J]. SAGE OPEN MEDICINE, 2018, 6
  • [5] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [6] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [7] Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.
    Gutierrez, K.
    Scheuermann, J.
    Goldvarg, I.
    Joshi, S.
    Tyson, G.
    Bzowej, N.
    Girgrah, N.
    Anders, S.
    Loss, G.
    Therapondos, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 793 - 794
  • [8] Sofosbuvir/ledipasvir and ribavirin tolerability and efficacy in pediatric liver transplant recipients
    Huysentruyt, Koen
    Stephenne, Xavier
    Varma, Sharat
    Scheers, Isabelle
    Leclercq, Gisele
    Smets, Francoise
    Sokal, Etienne M.
    [J]. LIVER TRANSPLANTATION, 2017, 23 (04) : 552 - 553
  • [9] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
  • [10] OUTCOME, SAFETY AND TOLERABILITY OF TREATING HEPATITIS C IN DECOMPENSATED CIRRHOTICS WITH LEDIPASVIR/SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: REAL LIFE DATA
    Selim, K.
    Long, W.
    Elhazin, B.
    Salazar, J.
    Karmanova, M.
    Volk, M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S788 - S788
12345